Market revenue in 2022 | USD 82.5 million |
Market revenue in 2030 | USD 199.4 million |
Growth rate | 11.7% (CAGR from 2023 to 2030) |
Largest segment | Ferric carboxymaltose |
Fastest growing segment | Other Product |
Historical data covered | 2018 - 2021 |
Base year for estimation | 2022 |
Forecast period covered | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Iron Dextran, Iron Sucrose, Ferric Carboxymaltose, Other Product |
Key market players worldwide | AbbVie Inc, Civitas Resources Inc Ordinary Shares, Daiichi Sankyo Co Ltd, Sanofi SA, CSL Ltd, COSMOS Pharmaceutical Corp, Zydus Lifesciences, Rockwell Medical Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to intravenous iron drugs market will help companies and investors design strategic landscapes.
Ferric carboxymaltose was the largest segment with a revenue share of 51.76% in 2022. Horizon Databook has segmented the Latin America intravenous iron drugs market based on iron dextran, iron sucrose, ferric carboxymaltose, other product covering the revenue growth of each sub-segment from 2018 to 2030.
The Latin America market region holds immense growth opportunities. In the developing economies of Latin America, the prevalence of iron deficiency anemia is high, which has resulted in potential demand for iron drugs. Such factors are anticipated to drive the regional market over the forecast period.
Growing healthcare expenditure is another factor boosting the regional market. The major countries in the Latin American market include Brazil, Mexico, and Argentina. Latin America includes rapidly evolving economies, including Brazil and Mexico. Increasing R&D activities, coupled with rapid technological advancements in the region, are anticipated to fuel market growth.
Increasing government spending, growing investments by major pharmaceutical & biopharmaceutical companies, and presence of major academic research institutes are among the factors likely to promote market growth.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America intravenous iron drugs market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America intravenous iron drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account